Modality-agnostic lab has already identified 8 novel treatments for previously untreatable rare diseases working directly with 30 families across four continents...

Takara Bio and Resistomap Oy today announce a strategic agreement to deepen their partnership in developing streamlined end-to-end solutions for high throughput ...

Japanese pharmaceutical companies are engaging contract development and manufacturing organisations (CDMOs) earlier in the development cycle, as increasing compl...

Despite advances in biomarker testing, real-world data shows progress is not translating into treatment decisions, with the largest patient loss now occurring at...

The World Markets Healthcare (WMH) service, which tracks changes in the operating environment for pharma and is offered by GlobalData, a leading intelligenc...

At the 2026 American Academy of Neurology (AAN) meeting, Xenon Pharmaceuticals announced positive results from the Phase III X-TOLE2 study of azetukalner, a nove...

Strengthens ECI's senior advisory expertise across quality, regulatory, and strategic growth initiatives Enhanced Compliance Inc. (ECI), a global life sci...

Crown Bioscience, a global contract research organisation (CRO) and a JSR Life Sciences company, today announced a strategic partnership with Turbine, a leading ...

ProBioGen announced the appointment of Dr Simon Johannes Bulling, PhD, as Chief Operating Officer (COO), effective April 15, 2026. In this role, Dr Bulling leads...

Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodolo...